Foley Todd
CIK 0001473930 Name as filed on the most recent filing
Filed as Foley Todd (82)
223 transaction lines · from 82 filings · filed 2011-11-22 to 2026-01-14 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Aktis Oncology, Inc. 1 filings
- ISSUER iTeos Therapeutics, Inc. 20 filings
- ISSUER Werewolf Therapeutics, Inc. 2 filings
- ISSUER Entrada Therapeutics, Inc. 2 filings
- ISSUER Repare Therapeutics Inc. 14 filings
- ISSUER Harpoon Therapeutics, Inc. 8 filings
- ISSUER Rhythm Pharmaceuticals, Inc. 24 filings
- ISSUER Oncorus, Inc. 1 filings
- ISSUER Tcr2 Therapeutics Inc. 1 filings
- ISSUER Aratana Therapeutics, Inc. 3 filings
- ISSUER Epizyme, Inc. 1 filings
- ISSUER Celladon Corp 1 filings
- ISSUER Conatus Pharmaceuticals Inc 1 filings
- ISSUER Pacira Pharmaceuticals, Inc. 2 filings
- ISSUER Verastem, Inc. 1 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
104 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-01-12 |
Aktis Oncology, Inc. AKTS |
P, Open-market purchase | 232,870 acquired | 18.00 | 4,191,660.00 | Form 4, filing 0001473930-26-000005 | |
| 2025-05-13 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 630,191 disposed | 8.06 | 5,079,339.46 | Form 4, filing 0001415889-25-013248 | |
| 2025-03-27 |
Werewolf Therapeutics, Inc. HOWL |
S, Open-market sale | 1,963 disposed | 1.05 | 2,061.15 | Form 4, filing 0001415889-25-011574 | |
| 2024-12-11 |
Entrada Therapeutics, Inc. TRDA |
S, Open-market sale | 21,787 disposed | 20.23 | 440,751.01 | Form 4, filing 0001415889-24-029141 | |
| 2024-12-10 |
Entrada Therapeutics, Inc. TRDA |
S, Open-market sale | 22,935 disposed | 20.77 | 476,359.95 | Form 4, filing 0001415889-24-029141 | |
| 2022-01-05 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 18,135 disposed | 42.03 | 762,214.05 | Form 4, filing 0001209191-22-002168 | |
| 2022-01-04 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 94,745 disposed | 42.05 | 3,984,027.25 | Form 4, filing 0001209191-22-002168 | |
| 2022-01-04 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 19,366 disposed | 43.20 | 836,611.20 | Form 4, filing 0001209191-22-002168 | |
| 2022-01-04 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 7,671 disposed | 46.47 | 356,471.37 | Form 4, filing 0001209191-22-002168 | |
| 2022-01-04 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 6,768 disposed | 45.32 | 306,725.76 | Form 4, filing 0001209191-22-002168 | |
| 2021-12-07 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 17,962 disposed | 33.15 | 595,440.30 | Form 4, filing 0001209191-21-068408 | |
| 2021-12-07 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 1,494 disposed | 34.11 | 50,960.34 | Form 4, filing 0001209191-21-068408 | |
| 2021-12-06 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 8,469 disposed | 32.35 | 273,972.15 | Form 4, filing 0001209191-21-068408 | |
| 2021-12-06 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 1,171 disposed | 33.57 | 39,310.47 | Form 4, filing 0001209191-21-068408 | |
| 2021-12-06 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 508 disposed | 34.08 | 17,312.64 | Form 4, filing 0001209191-21-068408 | |
| 2021-12-06 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 60 disposed | 35.04 | 2,102.40 | Form 4, filing 0001209191-21-068408 | |
| 2021-12-03 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 17,569 disposed | 34.68 | 609,292.92 | Form 4, filing 0001209191-21-068408 | |
| 2021-12-03 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 2,419 disposed | 35.44 | 85,729.36 | Form 4, filing 0001209191-21-068408 | |
| 2021-12-03 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 179 disposed | 36.26 | 6,490.54 | Form 4, filing 0001209191-21-068408 | |
| 2021-12-02 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 29,757 disposed | 33.74 | 1,004,001.18 | Form 4, filing 0001209191-21-067706 | |
| 2021-12-02 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 7,430 disposed | 34.83 | 258,786.90 | Form 4, filing 0001209191-21-067706 | |
| 2021-12-01 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 6,042 disposed | 33.82 | 204,340.44 | Form 4, filing 0001209191-21-067706 | |
| 2021-12-01 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 5,457 disposed | 34.61 | 188,866.77 | Form 4, filing 0001209191-21-067706 | |
| 2021-12-01 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 896 disposed | 35.34 | 31,664.64 | Form 4, filing 0001209191-21-067706 | |
| 2021-11-30 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 28,076 disposed | 35.19 | 987,994.44 | Form 4, filing 0001209191-21-067706 | |
| 2021-11-30 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 5,861 disposed | 34.62 | 202,907.82 | Form 4, filing 0001209191-21-067706 | |
| 2021-11-29 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 10,073 disposed | 34.46 | 347,115.58 | Form 4, filing 0001209191-21-067148 | |
| 2021-11-29 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 298 disposed | 35.37 | 10,540.26 | Form 4, filing 0001209191-21-067148 | |
| 2021-11-26 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 6,545 disposed | 35.49 | 232,282.05 | Form 4, filing 0001209191-21-067148 | |
| 2021-11-26 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 6,129 disposed | 36.03 | 220,827.87 | Form 4, filing 0001209191-21-067148 | |
| 2021-11-24 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 18,343 disposed | 36.05 | 661,265.15 | Form 4, filing 0001209191-21-066852 | |
| 2021-11-24 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 13,126 disposed | 37.02 | 485,924.52 | Form 4, filing 0001209191-21-066852 | |
| 2021-11-24 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 4,868 disposed | 35.20 | 171,353.60 | Form 4, filing 0001209191-21-066852 | |
| 2021-11-23 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 19,645 disposed | 36.21 | 711,345.45 | Form 4, filing 0001209191-21-066852 | |
| 2021-11-23 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 359 disposed | 36.50 | 13,103.50 | Form 4, filing 0001209191-21-066852 | |
| 2021-11-22 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 11,807 disposed | 37.81 | 446,422.67 | Form 4, filing 0001209191-21-066852 | |
| 2021-11-22 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 9,307 disposed | 37.16 | 345,848.12 | Form 4, filing 0001209191-21-066852 | |
| 2021-11-02 |
Entrada Therapeutics, Inc. TRDA |
P, Open-market purchase | 100,000 acquired | 20.00 | 2,000,000.00 | Form 4, filing 0001209191-21-062981 | |
| 2021-10-18 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 6,167 disposed | 27.14 | 167,372.38 | Form 4, filing 0001209191-21-060723 | |
| 2021-10-15 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 8,893 disposed | 27.53 | 244,824.29 | Form 4, filing 0001209191-21-060723 | |
| 2021-10-15 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 2,039 disposed | 28.01 | 57,112.39 | Form 4, filing 0001209191-21-060723 | |
| 2021-10-14 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 27,320 disposed | 27.30 | 745,836.00 | Form 4, filing 0001209191-21-060490 | |
| 2021-10-13 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 20,929 disposed | 27.13 | 567,803.77 | Form 4, filing 0001209191-21-060490 | |
| 2021-10-12 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 8,521 disposed | 27.09 | 230,833.89 | Form 4, filing 0001209191-21-060490 | |
| 2021-10-11 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 48,812 disposed | 27.24 | 1,329,638.88 | Form 4, filing 0001209191-21-060236 | |
| 2021-10-08 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 2,032 disposed | 27.01 | 54,884.32 | Form 4, filing 0001209191-21-060236 | |
| 2021-10-07 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 1,149 disposed | 27.00 | 31,023.00 | Form 4, filing 0001209191-21-060236 | |
| 2021-10-04 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 20,711 disposed | 27.06 | 560,439.66 | Form 4, filing 0001209191-21-059426 | |
| 2021-10-01 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 6,855 disposed | 27.00 | 185,085.00 | Form 4, filing 0001209191-21-059426 | |
| 2021-09-30 |
iTeos Therapeutics, Inc. ITOS |
S, Open-market sale | 2,292 disposed | 27.00 | 61,884.00 | Form 4, filing 0001209191-21-058209 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 6
- Open-market sale 98
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Foley Todd, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001473930
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6